HSPA5 and hyperlipidemia: The same ROC analysis was performed for the hyperlipidemia group, with HSP90AB1 (AUC=0.777), HSPA5 (AUC=0.838), and STUB1 (AUC=0.877) also showing robust predictive performance (Fig 9B, 9F and 9J).